BACKGROUND: Few studies have rigorously evaluated whether providing biologically based health-risk feedback is more effective than standard interventions in increasing smokers' motivation to quit and their long-term abstinence. DESIGN: An RCT was conducted from 2005 to 2008. Data were analyzed in 2008. SETTING/PARTICIPANTS: Smokers (N=536) were recruited from the community, regardless of their interest in quitting smoking. INTERVENTION: Smokers either received brief ( approximately 20 minutes), personally tailored counseling sessions based on their lung functioning, carbon monoxide (CO) exposure, and smoking-related health conditions, or they received generic smoking-risk information and personalized counseling about their diet, BMI, and physical activity. All were advised to quit smoking and were offered access to a free phone-counseling program. MAIN OUTCOME MEASURES: Treatment utilization and abstinence at 6 and 12 months post-intervention. RESULTS: Participants who received the experimental treatment demonstrated no greater motivation to quit, use of treatment services, or abstinence compared to controls at either follow-up assessment. In fact, controls reported greater motivation to quit at 12 months (M 3.42 vs 3.20, p=0.03), greater use of pharmacotherapy at 6 months (37.8% vs 28.0%, p=0.02), and greater 30-day point prevalent abstinence at 6 months, after controlling for relevant covariates (10.8% vs 6.4%, adjusted p=0.04). CONCLUSIONS: The present study found no support for adding a personalized health-risk assessment emphasizing lung health and CO exposure to generic cessation advice and counseling for community-based smokers not otherwise seeking treatment. TRIAL REGISTRATION: NCT00169260.
RCT Entities:
BACKGROUND: Few studies have rigorously evaluated whether providing biologically based health-risk feedback is more effective than standard interventions in increasing smokers' motivation to quit and their long-term abstinence. DESIGN: An RCT was conducted from 2005 to 2008. Data were analyzed in 2008. SETTING/PARTICIPANTS: Smokers (N=536) were recruited from the community, regardless of their interest in quitting smoking. INTERVENTION: Smokers either received brief ( approximately 20 minutes), personally tailored counseling sessions based on their lung functioning, carbon monoxide (CO) exposure, and smoking-related health conditions, or they received generic smoking-risk information and personalized counseling about their diet, BMI, and physical activity. All were advised to quit smoking and were offered access to a free phone-counseling program. MAIN OUTCOME MEASURES: Treatment utilization and abstinence at 6 and 12 months post-intervention. RESULTS:Participants who received the experimental treatment demonstrated no greater motivation to quit, use of treatment services, or abstinence compared to controls at either follow-up assessment. In fact, controls reported greater motivation to quit at 12 months (M 3.42 vs 3.20, p=0.03), greater use of pharmacotherapy at 6 months (37.8% vs 28.0%, p=0.02), and greater 30-day point prevalent abstinence at 6 months, after controlling for relevant covariates (10.8% vs 6.4%, adjusted p=0.04). CONCLUSIONS: The present study found no support for adding a personalized health-risk assessment emphasizing lung health and CO exposure to generic cessation advice and counseling for community-based smokers not otherwise seeking treatment. TRIAL REGISTRATION: NCT00169260.
Authors: Jennifer B McClure; Julie Richards; Emily O Westbrook; Chester Pabiniak; Evette Ludman Journal: Am J Prev Med Date: 2007-11 Impact factor: 5.043
Authors: M Bednarek; D Gorecka; J Wielgomas; M Czajkowska-Malinowska; J Regula; G Mieszko-Filipczyk; M Jasionowicz; R Bijata-Bronisz; M Lempicka-Jastrzebska; M Czajkowski; G Przybylski; J Zielinski Journal: Thorax Date: 2006-06-29 Impact factor: 9.139
Authors: Timothy J Wilt; Dennis Niewoehner; Robert L Kane; Roderick MacDonald; Anne M Joseph Journal: Nicotine Tob Res Date: 2007-01 Impact factor: 4.244
Authors: J B McClure; H Derry; K R Riggs; E W Westbrook; J St John; S M Shortreed; A Bogart; L C An Journal: Contemp Clin Trials Date: 2012-07-04 Impact factor: 2.226
Authors: José S Marcano Belisario; Michelle N Bruggeling; Laura H Gunn; Serena Brusamento; Josip Car Journal: Cochrane Database Syst Rev Date: 2012-12-12
Authors: Francisco Martin-Lujan; Josep L I Piñol-Moreso; Nuria Martin-Vergara; Josep Basora-Gallisa; Irene Pascual-Palacios; Ramon Sagarra-Alamo; Estefania Aparicio Llopis; Maria T Basora-Gallisa; Roser Pedret-Llaberia Journal: BMC Public Health Date: 2011-11-11 Impact factor: 3.295
Authors: Aaron C Lim; Kelly E Courtney; Nathasha R Moallem; Vincent C Allen; Adam M Leventhal; Lara A Ray Journal: Front Psychiatry Date: 2018-08-10 Impact factor: 4.157
Authors: Jennifer D Marler; Craig A Fujii; Kristine S Wong; Joseph A Galanko; Daniel J Balbierz; David S Utley Journal: J Med Internet Res Date: 2020-10-02 Impact factor: 5.428